Evaluation of gefitinib efficacy according to body surface area in patients with non-small cell lung cancer harboring an EGFR mutation
Crossref DOI link: https://doi.org/10.1007/s00280-014-2570-1
Published Online: 2014-08-31
Published Print: 2014-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Igawa, Satoshi
Kasajima, Masashi
Ishihara, Mikiko
Kimura, Michiko
Hiyoshi, Yasuhiro
Niwa, Hideyuki
Kusuhara, Seiichiro
Harada, Shinya
Asakuma, Maiko
Otani, Sakiko
Katono, Ken
Sasaki, Jiichiro
Masuda, Noriyuki
Text and Data Mining valid from 2014-08-31